Clinical manifestations of leprosy after BCG vaccination: An observational study in Bangladesh

Vaccine

Volumn 33, Issue 13, 2015, Pages 1562-1567

  Richardus, Renate A ^a   Butlin, C Ruth ^b   Alam, Khorshed ^b   Kundu, Kallyan ^b   Geluk, Annemieke ^c   Richardus, Jan Hendrik ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Danish Bangladesh Leprosy Mission   (Bangladesh)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG; Contacts; Leprosy; M. leprae; Prevention; Prophylaxis

Indexed keywords

BCG VACCINE; RIFAMPICIN; BACTERIAL ANTIGEN; LEPROSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BANGLADESH; BCG VACCINATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTACT EXAMINATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LEPROSY; MALE; MIDDLE AGED; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; NERVE FUNCTION; NEUROPATHY; OBSERVATIONAL STUDY; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR; SCHOOL CHILD; SINGLE DRUG DOSE; YOUNG ADULT; CELLULAR IMMUNITY; COMBINATION DRUG THERAPY; FAMILY SIZE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOLOGY; LEPROSY, PAUCIBACILLARY; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BANGLADESH; BCG VACCINE; CHILD; DRUG THERAPY, COMBINATION; FAMILY CHARACTERISTICS; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNITY, CELLULAR; LEPROSTATIC AGENTS; LEPROSY, PAUCIBACILLARY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; RIFAMPIN; VACCINATION; YOUNG ADULT;

EID: 84924974631     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.017     Document Type: Article

References (32)

1. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994, 271(9):698-702.
2. Lalor M.K., Ben-Smith A., Gorak-Stolinska P., Weir R.E., Floyd S., Blitz R., et al. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis 2009, 199(6):795-800.
3. Lalor M.K., Floyd S., Gorak-Stolinska P., Ben-Smith A., Weir R.E., Smith S.G., et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011, 204(7):1075-1085.
4. Lalor M.K., Smith S.G., Floyd S., Gorak-Stolinska P., Weir R.E., Blitz R., et al. Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 2010, 28(6):1635-1641.
5. Merle C.S., Cunha S.S., Rodrigues L.C. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines 2010, 9(2):209-222.
6. Setia M.S., Steinmaus C., Ho C.S., Rutherford G.W. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 2006, 6(3):162-170.
7. Duthie M.S., Gillis T.P., Reed S.G. Advances and hurdles on the way toward a leprosy vaccine. Hum. Vaccines 2011, 7(11):1172-1183.
8. Richardus J.H., Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol 2015, 33(1):19-25.
9. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., et al. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci USA 2003, 100(13):7877-7882.
10. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409(6823):1007-1011.
11. Duppre N.C., Camacho L.A., da Cunha S.S., Struchiner C.J., Sales A.M., Nery J.A., et al. Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Trans R Soc Trop Med Hyg 2008, 102(7):631-638.
12. Moet F.J., Pahan D., Oskam L., Richardus J.H. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008, 336(7647):761-764.
13. Schuring R.P., Richardus J.H., Pahan D., Oskam L. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine 2009, 27(50):7125-7128.
14. Richardus R.A., Alam K., Pahan D., Feenstra S.G., Geluk A., Richardus J.H. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). BMC Infect Dis 2013, 13:456.
15. Bangladesh Bureau of Statistics Bangladesh population & housing census 2011, Bangladesh Bureau of Statistics, Available from http://www.bbs.gov.bd [cited 2013 9 September].
16. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966, 34(3):255-273.
17. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A., Ifrim D.C., Saeed S., et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012, 109(43):17537-17542.
18. Wade H.W. BCG-Induced Activations. Int J Lepr 1960, 28(2):179-181.
19. Lwin K., Sundaresan T., Gyi M.M., Bechelli L.M., Tamondong C., Garbajosa P.G., et al. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull World Health Organ 1985, 63(6):1069-1078.
20. Karonga_Prevention_Trial_Group Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996, 348(9019):17-24.
21. Aaby P., Kollmann T.R., Benn C.S. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 2014, 15(10):895-899.
22. Roth A., Sodemann M., Jensen H., Poulsen A., Gustafson P., Weise C., et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 2006, 17(5):562-568.
23. Sallam M.A., Attia E.A., Soliman M.S. Assessment of serum level of interleukin-1b and interleukin-12 in leprosy: impact of previous Bacillus Calmitte Guerin vaccination. Arch Dermatol Res 2014, 306(2):189-195.
24. + induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J Infect Dis 2011, 204(10):1573-1584.
25. Goldsack L., Kirman J.R. Half-truths and selective memory: interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 2007, 87(6):465-473.
26. Kagina B.M., Abel B., Scriba T.J., Hughes E.J., Keyser A., Soares A., et al. Specific T-cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after Bacillus Calmette-Guerin vaccination of newborns. Am J Respir Crit Care Med 2010, 182(8):1073-1079.
27. Mittrucker H.W., Steinhoff U., Kohler A., Krause M., Lazar D., Mex P., et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007, 104(30):12434-12439.
28. Kleinnijenhuis J., Quintin J., Preijers F., Benn C.S., Joosten L.A., Jacobs C., et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014, 6(2):152-158.
29. Bagshawe A., Scott G.C., Russell D.A., Wigley S.C., Merianos A., Berry G. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bull World Health Organ 1989, 67(4):389-399.
30. Deps P., Lockwood D.N. Leprosy presenting as immune reconstitution inflammatory syndrome: proposed definitions and classification. Lepr Rev 2010, 81:59-68.
31. Kar H.K., Sharma P., Bhardwaj M. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome. Lepr Rev 2009, 80(1):85-88.
32. Smith S.G., Lecher S., Blitz R., Locht C., Dockrell H.M. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012, 42(9):2511-2522.